Medical Innovation Exchange

R&D

DiMe Convenes Industry Leaders to Streamline Commercialization of Digital Health Products

DiMe Convenes Industry Leaders to Streamline Commercialization of Digital Health Products     The Digital Medicine Society (DiMe) has announced that it is partnering with Peterson Health Technology Institute (PHTI), ZS Associates and other leading industry organizations to define how Integrated Evidence Plans (IEP) can be developed, optimized and used to support the regulatory and commercial success of digital health products (DHPs) on …

DiMe Convenes Industry Leaders to Streamline Commercialization of Digital Health Products Read More »

Three Steps to Gain the Full Advantage of Pharmaceutical Business Forecasting

Three Steps to Gain the Full Advantage of Pharmaceutical Business Forecasting     Business strategy and forecasting influence several functional areas within an organization. These relationships may be in one direction (where forecasts feed into decisions made by the other functional areas) or in many directions (where the forecast is used to generate changes proposed by …

Three Steps to Gain the Full Advantage of Pharmaceutical Business Forecasting Read More »

A Single Source of Truth Helps Regulatory Teams

A Single Source of Truth Helps Regulatory Teams     Regulatory teams participate in every step of bringing a medical device or drug to market. Because of the essential role they play, these teams need advanced tools to keep pace with the latest regulatory bodies and standards. Legacy technology that siloes data across different pillars isn’t …

A Single Source of Truth Helps Regulatory Teams Read More »